Abstract
BACKGROUND: The COVID-19 pandemic has boosted the use of forced expiratory volume in 1 second (FEV(1)) telemonitoring in pediatric asthma, but a consensus on its most efficient and effective implementation is still lacking. To find answers, it is important to study how such an intervention is perceived, experienced, and used by both patients and health care professionals (HCPs). OBJECTIVE: The aim of this study was to provide perspectives on how FEV(1) home monitoring should be used in pediatric asthma. METHODS: This is a qualitative, multicenter, prospective, observational study which included patients with asthma aged 6-16 and HCPs. Primary outcomes were results of 2 surveys that were sent to all participants at study start and after 3-4 months. Secondary outcomes consisted of FEV(1) device usage during 4 months after receiving the FEV(1) device. RESULTS: A total of 39 participants (26 patients and 13 HCPs) were included in this study. Survey response rates were 97% (38/39) at the start and 87% (34/39) at the end of the study. Both patients and HCPs were receptive toward online FEV(1) home monitoring and found it contributive to asthma control, self-management, and disease perception. The main concerns were about reliability of the FEV(1) device and validity of home-performed lung function maneuvers. FEV(1) devices were used with a median frequency of 7.5 (IQR 3.3-25.5) during the 4-month study period. CONCLUSIONS: Patients and HCPs are receptive toward online FEV(1) home monitoring. Frequency of measurements varied largely among individuals, yet perceived benefits remained similar. This emphasizes that online FEV(1) home monitoring strategies should be used as a means to reach individual goals, rather than being a goal on their own.